SCHEMBL25857068

SCHEMBL25857068

C=CC1OC(C=C)C2C(=O)N(CCN/C(N)=N/C(=O)NCc3ccccc3)C(=O)C12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
LMNA P02545 2/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ELANE P08246 1/20 0.36
TPSAB1 Q15661 1/20 0.35
TPSD1 Q9BZJ3 1/20 0.35
TPSG1 Q9NRR2 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
POLB P06746 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MC4R P32245 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25857056 0.96 ALDH1A1 (0.46) ALDH1A1LMNAMEN1KMT2AELANE
SCHEMBL25857077 0.89 ALDH1A1 (0.41) ALDH1A1LMNAMEN1KMT2AELANE
SCHEMBL25857050 0.87 ALDH1A1 (0.43) ALDH1A1LMNAMEN1KMT2AELANE
SCHEMBL25857062 0.87 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ATPSAB1TPSD1
SCHEMBL25857043 0.86 ALDH1A1 (0.52) ALDH1A1LMNATPSAB1TPSD1TPSG1
SCHEMBL25857060 0.85 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ASMN1; SMN2OPRM1
SCHEMBL24746658 0.82 ALDH1A1 (0.52) ALDH1A1LMNATPSAB1TPSD1TPSG1
SCHEMBL25857078 0.79 ALDH1A1 (0.40) ALDH1A1MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL24746998 0.79 ALDH1A1 (0.38) ALDH1A1LMNAELANETPSAB1TPSD1
SCHEMBL25857058 0.78 ALDH1A1 (0.37) ALDH1A1MEN1KMT2AOPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11801228-B2 Modified guanidine-containing polymers for biologic delivery THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2023-10-31 US disclosed
US-20230225982-A1 MODIFIED GUANIDINE-CONTAINING POLYMERS FOR BIOLOGIC DELIVERY THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230225982-A1 MODIFIED GUANIDINE-CONTAINING POLYMERS FOR BIOLOGIC DELIVERY GMPS, RNMT, GUCY1A1 ALDH1A1 1829/4885LMNA 2545/4885MEN1 2661/4885
US-11801228-B2 Modified guanidine-containing polymers for biologic delivery GMPS, RNMT, GUCY1A1 ALDH1A1 1829/4885LMNA 2545/4885MEN1 2661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.